The deal comes after the Supreme Court blocked a controversial bankruptcy plan for Purdue that shielded Sackler family members from future lawsuits.

Purdue Pharma ... its chapter 11 case and could be subject to objections. “For decades, the Sacklers recklessly marketed their opioid products without concern for the law, safety, or the ...

Members of the family who own OxyContin maker Purdue Pharma, and the company itself ... In an October 2024 filing, one branch ...

The yearslong bankruptcy case could be coming to a close. Purdue Pharma’s owners in the Sackler family have agreed to a new $6.5 billion settlement to lawsuits over their role in the U.S. opioid ...

Purdue Pharma and the members of the Sackler family who own the company agreed in principle to pay a $7.4 billion settlement to resolve thousands of lawsuits over their alleged role in the opioid ...

The Sackler family and Purdue Pharma, the maker of the addictive painkiller oxycontin, have reached a $7.4 billion settlement ...

If approved, Purdue Pharma ... bankruptcy law. However, they will be permitted to set aside up to $800 million in a separate account that can only be used to fight legal cases, the New York ...

A bipartisan coalition of states has reached a $7.4 billion settlement in principle with members of the Sackler family and their former company Purdue Pharma over their role in the opioid crisis.

Members of the family who own OxyContin maker Purdue Pharma, and the company itself ... one branch of the family pledged to defend itself in any cases that are allowed to move ahead, saying ...

Purdue Pharma’s owners from the Sackler family have ... reopening a path to end the longest and costliest corporate bankruptcy case stemming from the U.S. opioid crisis. The Sackler family ...